Related Experiment Video
Updated: Aug 8, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Candida parapsilosis peritonitis has more complications than other Candida peritonitis in peritoneal dialysis
Kuan-Hsing Chen1, Chiz-Tsung Chang, Chun-Chen Yu
1Division of Nephrology, Chang Gung Memorial Hospital and Chang Gung University, Taipei, Taiwan.
Abstract:
Candida parapsilosis is the most prevalent pathogen of fungal peritonitis in peritoneal dialysis (PD). The difference between C. parapsilosis peritonitis and other C. species for clinical outcomes and treatment responses to fungal peritonitis remains unclear. This retrospective study of fungal peritonitis attempts to answer that question. A total 22 patients with fungal peritonitis in 762 PD patients were enrolled in this study. The mean age of the 22 patients, 9 males and 13 females, was 54.7 +/- 12.5 years with a mean PD duration of 39.7 +/- 33.4 months. Candida species accounted for 86% (19 cases) of fungal peritonitis and 41% (9 cases) were C. parapsilosis. Thirteen (59%) patients received fluconazole as monotherapy; others received either amphotericin B alone or in combination with fluconazole. Catheters were removed for all patients. The mean duration from peritonitis onset to catheter removal was 5.8 +/- 4.1 days. Eleven (50%) patients developed severe complications, with abscess formation or persistent peritonitis after catheter removal. C. parapsilosis peritonitis had a higher complication rate than other Candida species (78% versus 20%, p = 0.012). In patients who received fluconazole as monotherapy, the rate of severe complications of C. parapsilosis peritonitis was statistically higher than those of other Candida species (100% versus 29%, p = 0.013). Because of different severity and prognosis, C. parapsilosis peritonitis in PD patients should be treated more aggressively than other Candida species.
Insights
Candida parapsilosis peritonitis in peritoneal dialysis patients leads to more severe complications. Aggressive treatment is recommended for C. parapsilosis compared to other Candida species to improve outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Nephrology
Background:
- Fungal peritonitis is a serious complication in peritoneal dialysis (PD).
- Candida parapsilosis is the most common cause of fungal peritonitis in PD patients.
- Clinical outcomes and treatment responses for C. parapsilosis peritonitis are not well understood compared to other Candida species.
Purpose of the Study:
- To compare the clinical outcomes and complication rates of C. parapsilosis peritonitis versus other Candida species in PD patients.
- To evaluate treatment responses and identify factors influencing severity.
Main Methods:
- Retrospective study of 22 PD patients with fungal peritonitis.
- Analysis of patient demographics, PD duration, causative Candida species, and treatment regimens.
- Comparison of complication rates and outcomes between C. parapsilosis and other Candida species.
Main Results:
- Candida species caused 86% of fungal peritonitis cases; C. parapsilosis accounted for 41% (9 cases).
- C. parapsilosis peritonitis had a significantly higher rate of severe complications (78% vs. 20%, p=0.012).
- In patients treated with fluconazole monotherapy, C. parapsilosis peritonitis showed a higher complication rate (100% vs. 29%, p=0.013).
Conclusions:
- Candida parapsilosis peritonitis in PD patients is associated with a higher risk of severe complications.
- Treatment strategies for C. parapsilosis peritonitis may require more aggressive approaches compared to other Candida species.
- Further research into optimal management of C. parapsilosis peritonitis in PD is warranted.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Candidiasis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Acute Pancreatitis II: Pathophysiology
